EGFR and cancer: Our data demonstrate that initiating genetic events (EGFR-mut, KRAS-mut or variable in NEK) influence the subsequent pattern of stabilizing and directional selection on other genes and molecular pathways consistent with driver-dependent coadapted syndromes for each cancer type.